Abiogen Pharma Competitors and Similar CompaniesClear all
Pharming Group's competitors and similar companies include Alexion Pharmaceuticals and Crinetics Pharmaceuticals.
 Pharming Group Pharming Group is a biopharmaceutical company developing protein replacement therapies and precision medicines for the treatment of rare diseases. |  Alexion Pharmaceuticals Alexion (also known as Alexion, AstraZeneca Rare Disease) is a biopharmaceutical company engaged in therapies for rare diseases. |  Crinetics Pharmaceuticals Crinetics Pharmaceuticals is a clinical-stage pharmaceutical company that develops and commercializes therapeutics for rare endocrine diseases and endocrine-related tumors. | |
Founding Date | Founding Date 1988 | Founding Date 1992 | Founding Date 2008 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Leiden, NL HQ Leiden, NL | Locations Boston, US HQ Frenchs Forest, AU Wien, AT Elsene, BE São Paulo, BR Vaughan, CA Shanghai, CN see more | Locations San Diego, US HQ |
Employees | Employees 404 | Employees 10,6006% increase | Employees 43751% increase |
Valuation ($) | Valuation ($) 590.3 m | Valuation ($) 40.3 b | Valuation ($) 5.1 b |
Financial | |||
Revenue (est.) | Revenue (est.) $376.1m (FY, 2025) | Revenue (est.) $6.1b (FY, 2020) | Revenue (est.) $7.7m (FY, 2025) |
Cost of goods | Cost of goods $41.6m (FY, 2025) | Cost of goods $553.5m (FY, 2020) | Cost of goods $1.1m (FY, 2025) |
Gross profit | Gross profit $341m (FY, 2025) | Gross profit $5.5b (FY, 2020) | Gross profit $6.6m (FY, 2025) |
Net income | Net income $2.5m (FY, 2025) | Net income $603.4m (FY, 2020) | Net income ($465.3m) (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Alexion Pharmaceuticals
HQ
Boston, US
Employees
10,600↑ 6% increase
Alexion (also known as Alexion, AstraZeneca Rare Disease) is a biopharmaceutical company engaged in therapies for rare diseases.
View companyCrinetics Pharmaceuticals
HQ
San Diego, US
Employees
437
Crinetics Pharmaceuticals is a clinical-stage pharmaceutical company that develops and commercializes therapeutics for rare endocrine diseases and endocrine-related tumors.
View company